These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17251734)

  • 1. Importance of realistic sample size calculations and why the next randomized trial needs to be large and multicentered.
    Li TS; Lee A; Joynt GM
    Crit Care Med; 2007 Feb; 35(2):675-6. PubMed ID: 17251734
    [No Abstract]   [Full Text] [Related]  

  • 2. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of effect size in randomized controlled trials.
    Fujita T
    Arch Surg; 2010 Apr; 145(4):400-1; author reply 401. PubMed ID: 20404296
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of data from an ongoing randomized clinical trial for sample size adjustment or planning.
    Freidlin B; Korn EL
    Stat Med; 2007 Sep; 26(22):4074-82. PubMed ID: 17328095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How many patients do we need for a clinical trial? Demystifying sample size calculations.
    Kelly PJ; Webster AC; Craig JC
    Nephrology (Carlton); 2010 Dec; 15(8):725-31. PubMed ID: 21175958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 7. [Failures in sample size calculation in randomized trial: mandatory and mystical].
    Schulz KF; Grimes DA
    Z Arztl Fortbild Qualitatssich; 2006; 100(2):129-35. PubMed ID: 16686447
    [No Abstract]   [Full Text] [Related]  

  • 8. Power and sample size simulations for Randomized Play-the-Winner rules.
    Guimaraes P; Palesch Y
    Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
    Ospina-Tascón GA; Büchele GL; Vincent JL
    Crit Care Med; 2008 Apr; 36(4):1311-22. PubMed ID: 18379260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How important is exact balance in treatment and control sample sizes to evaluations?
    Elliott MN; McCaffrey DF; Lockwood JR
    J Subst Abuse Treat; 2007 Jul; 33(1):107-10. PubMed ID: 17376636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining a proper sample size.
    Fogel J
    Fam Pract Manag; 2004 Oct; 11(9):14; author reply 14. PubMed ID: 15552243
    [No Abstract]   [Full Text] [Related]  

  • 14. Sizing a trial to alter the trajectory of health behaviours: methods, parameter estimates, and their application.
    Murray DM; Blitstein JL; Hannan PJ; Baker WL; Lytle LA
    Stat Med; 2007 May; 26(11):2297-316. PubMed ID: 17044139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of reporting of randomized controlled trials in solid organ transplantation.
    Pengel LH; Barcena L; Morris PJ
    Transpl Int; 2009 Apr; 22(4):377-84. PubMed ID: 19000234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
    Scales CD; Norris RD; Preminger GM; Vieweg J; Peterson BL; Dahm P
    J Urol; 2008 Oct; 180(4):1463-7. PubMed ID: 18710745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagram of reliability and net gain: a new method for summarizing and displaying the results of controlled trials.
    Cruccu G; Taylor RS
    Pain Pract; 2007 Sep; 7(3):230-3. PubMed ID: 17714101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating clinical literature.
    Strite S; Stuart ME
    Fam Pract Manag; 2004 Oct; 11(9):14, 16; author reply 16. PubMed ID: 15552244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.